Duloxetine

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

5HT1 agonists, Alcohol, Amitriptyline, Artemether/Lumefantrine, Aspirin, Atomoxetine, Cimetidine, Ciprofloxacin, Citalopram, Clomipramine, CYP1A2 inducers, CYP2D6 inhibitors and substrates, Darunavir, Droperidol, Enoxacin, Fesoterodine, Fluoxetine, Fluvoxamine, Iobenguane, Levomepromazine, MAO inhibitors, Meperidine, Moclobemide, Naratriptan, Nebivolol, NSAIDs, Paroxetine Hydrochloride, PEG-Interferon, Quinidine, Sibutramine, SSRIs, St John's Wort, Tamoxifen, Teriflunomide, Thioridazine, Tramadol, Tricyclic antidepressants, Tryptophan, Venlafaxine, Warfarin

PREGNANCY CATEGORY: C

SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

Our database has 114 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of duloxetine in the Informa Healthcare journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 01/02/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top